S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Twitter executive responsible for content safety resigns after Elon Musk criticism
NYSE:MD

Pediatrix Medical Group (MD) Stock Forecast, Price & News

$13.99
+0.43 (+3.17%)
(As of 06/2/2023 ET)
Compare
Today's Range
$13.74
$14.16
50-Day Range
$13.02
$14.98
52-Week Range
$12.84
$23.95
Volume
432,712 shs
Average Volume
479,830 shs
Market Capitalization
$1.17 billion
P/E Ratio
11.47
Dividend Yield
N/A
Price Target
$17.67

Pediatrix Medical Group MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
26.3% Upside
$17.67 Price Target
Short Interest
Healthy
4.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.18mentions of Pediatrix Medical Group in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$681,385 Sold Last Quarter
Proj. Earnings Growth
9.66%
From $1.45 to $1.59 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.60 out of 5 stars

Medical Sector

92nd out of 983 stocks

Hospitals Industry

3rd out of 3 stocks


MD stock logo

About Pediatrix Medical Group (NYSE:MD) Stock

Pediatrix Medical Group, Inc. engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

MD Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Pediatrix Medical Group (NYSE: MD)
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Pediatrix Medical Group (NYSE:MD) PT Lowered to $14.00
Pediatrix Medical Group (NYSE:MD) PT Lowered to $15.00
Q1 2023 Pediatrix Medical Group Inc Earnings Call
See More Headlines

MD Price History

MD Company Calendar

Last Earnings
10/28/2021
Today
6/03/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
58502B10
Employees
5,250
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$17.67
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+26.3%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$66.33 million
Pretax Margin
6.58%

Debt

Sales & Book Value

Annual Sales
$1.97 billion
Cash Flow
$2.08 per share
Book Value
$10.86 per share

Miscellaneous

Free Float
82,085,000
Market Cap
$1.17 billion
Optionable
Optionable
Beta
1.75

Social Links


Key Executives

  • James D. Swift
    Chief Executive Officer & Director
  • Curtis B. Pickert
    Chief Operating Officer & Executive Vice President
  • C. Mark Richards
    Chief Financial Officer & Executive Vice President
  • Reese H. Clark
    Senior VP-Clinical Research & Education
  • Dana Dreher-Rodwell
    Chief Compliance Officer & Vice President













MD Stock - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings
or view top-rated stocks.

What is Pediatrix Medical Group's stock price forecast for 2023?

5 brokers have issued 1-year price objectives for Pediatrix Medical Group's shares. Their MD share price forecasts range from $14.00 to $23.00. On average, they expect the company's share price to reach $17.67 in the next twelve months. This suggests a possible upside of 26.3% from the stock's current price.
View analysts price targets for MD
or view top-rated stocks among Wall Street analysts.

How have MD shares performed in 2023?

Pediatrix Medical Group's stock was trading at $14.86 at the beginning of the year. Since then, MD shares have decreased by 5.9% and is now trading at $13.99.
View the best growth stocks for 2023 here
.

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our MD earnings forecast
.

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) issued its earnings results on Thursday, October, 28th. The company reported $0.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.41 by $0.05. The company earned $493 million during the quarter, compared to analyst estimates of $480.04 million. Pediatrix Medical Group had a trailing twelve-month return on equity of 13.85% and a net margin of 5.14%. The company's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.33 earnings per share.

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

What is Pediatrix Medical Group's stock symbol?

Pediatrix Medical Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

Who are Pediatrix Medical Group's major shareholders?

Pediatrix Medical Group's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.10%), Dimensional Fund Advisors LP (4.61%), State Street Corp (4.08%), ArrowMark Colorado Holdings LLC (3.15%), River Road Asset Management LLC (1.91%) and Geode Capital Management LLC (1.85%). Insiders that own company stock include John C Pepia, Mark S Ordan, Nicholas J Nikolopoulos, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends
.

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pediatrix Medical Group's stock price today?

One share of MD stock can currently be purchased for approximately $13.99.

How much money does Pediatrix Medical Group make?

Pediatrix Medical Group (NYSE:MD) has a market capitalization of $1.17 billion and generates $1.97 billion in revenue each year. The company earns $66.33 million in net income (profit) each year or $1.22 on an earnings per share basis.

How many employees does Pediatrix Medical Group have?

The company employs 5,250 workers across the globe.

How can I contact Pediatrix Medical Group?

Pediatrix Medical Group's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The official website for the company is www.mednax.com. The company can be reached via phone at (954) 384-0175, via email at charles_lynch@mednax.com, or via fax at 954-838-9961.

This page (NYSE:MD) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -